Skip to content

COMPARISION OF TWO LOCAL ANESTHETIC DRUGS WITH ADJUVANT FOR SPINAL ANESTHESIA IN LOWER LIMB SURGERIES

COMPARISION OF HYPERBARIC BUPIVACAINE AND HYPERBARIC ROPIVACAINE WITH DEXMEDETOMIDINE AS AN ADJUVANT IN SPINAL ANESTHESIA FOR LOWER LIMB SURGERIES- A RANDOMISED CONTROL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050773
Enrollment
88
Registered
2023-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur Health Condition 2: S826- Fracture of lateral malleolus Health Condition 3: S724- Fracture of lower end of femur Health Condition 4: S823- Fracture of lower end of tibia Health Condition 5: S825- Fracture of medial malleolus Health Condition 6: S820- Fracture of patella Health Condition 7: S723- Fracture of shaft of femur Health Condition 8: S824- Fracture of shaft of fibula Health Condition 9: S822- Fracture of shaft of tibia Health C

Interventions

Intervention1: Hyperbaric ropivacaine with dexmedetomidine: 2.5 ml of hyperbaric ropivacaine (0.75%) with 10 mcg of dexmedetomidine intrathecally, effects observed for 24 hrs after spinal anesthesia.

Sponsors

BPS govt medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (A)ASA physical status l and II patients between age group 18-65 years posted for elective lower limb surgeries. (B)Patients giving written informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1.Patientâ??s refusal to participate in study. 2.Any contraindication to spinal anesthesia: a.Infection at the site of injection b.Raised Intracranial Pressure c.Pre-Existing neurological deficits d.Bleeding disorders e.Severe Hypovolemia f.Patients with anatomical spinal deformity 3.History of allergy to drugs under study. 4.Patients having underlying systemic disorders (history of uncontrolled diabetes mellitus, hypertension, peptic ulcer disease, glaucoma, fungal or viral infection). 5.History of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic diseases.

Design outcomes

Primary

MeasureTime frame
To determine the blockade characteristics (i.e., onset and duration of sensory blockade) after administration of spinal anesthesia with hyperbaric bupivacaine (0.5%) and hyperbaric ropivacaine (0.75%) with dexmedetomidine as an adjuvant for conduct of lower limb surgeries in both the groups. Timepoint: Patients will be assessed bilaterally for loss of cold sensation to spirit swab in the anterior axillary line at every 1-minute interval till maximum blockade achieved at T10 level for 5-10 minutes.Duration of sensory blockade will be taken as when the patient complained of pain at the surgical site i.e., need for first rescue analgesia.

Secondary

MeasureTime frame
Motor blockade and hemodynamic changesTimepoint: At every minute interval, motor blockade assessment will be done till maximum motor blockade achieved (Grade 3). Duration of motor blockade will be taken from the onset of motor blockade to complete motor recovery (Grade 0). Blood pressure, heart rate and oxygen saturation will be measured every 1 minutes after the administration of spinal anesthesia for first 5 minutes then every 5 minutes till the completion of surgery

Countries

India

Contacts

Public ContactDr Rishika Parihar

Bhagat Phool SINGH Government Medical College FOR Wome

pranavbansal1@gmail.com8222007555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026